Sight Sciences (NASDAQ: SGHT)
Sight Sciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Sight Sciences Company Info
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2010 and is headquartered in Menlo Park, CA.
News & Analysis
Here's What Investors Need to Know About Sight Sciences Stock
The company is a newer player in the medical devices space.
Should Investors Consider Sight Sciences Stock?
The company recently became publicly traded.
Valuation
Earnings Transcripts
Sight Sciences, Inc. (SGHT) Q2 2022 Earnings Call Transcript
SGHT earnings call for the period ending June 30, 2022.
Sight Sciences, Inc. (SGHT) Q1 2022 Earnings Call Transcript
SGHT earnings call for the period ending March 31, 2022.
Sight Sciences, Inc. (SGHT) Q4 2021 Earnings Call Transcript
SGHT earnings call for the period ending December 31, 2021.
Sight Sciences, Inc. (SGHT) Q3 2021 Earnings Call Transcript
SGHT earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.